{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:30:45Z","timestamp":1793619045794,"version":"4.5.0"},"reference-count":127,"publisher":"Informa UK Limited","issue":"11","license":[{"start":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:00:00Z","timestamp":1789862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"National Natural Science Foundation of China","award":["82273782"],"award-info":[{"award-number":["82273782"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of China","award":["82504589"],"award-info":[{"award-number":["82504589"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Henan Provincial Science and Technology Research Project","award":["262102311204"],"award-info":[{"award-number":["262102311204"]}]},{"name":"Training Program for Young Key Teachers of Colleges and Universities in Henan Province","award":["2023GGJS008"],"award-info":[{"award-number":["2023GGJS008"]}]},{"name":"Program for Scientific and Technological Innovation Talents in Universities of Henan Province","award":["26HASTIT053"],"award-info":[{"award-number":["26HASTIT053"]}]},{"name":"National Natural Science Foundation of Henan","award":["242300421472"],"award-info":[{"award-number":["242300421472"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2026,11,2]]},"DOI":"10.1080\/13543776.2026.2735861","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T03:44:52Z","timestamp":1789703092000},"page":"1045-1058","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Progress with FAK inhibitors in the patent literature (2020-present)"],"prefix":"10.1080","volume":"36","author":[{"given":"Bing-Bing","family":"Chen","sequence":"first","affiliation":[{"name":"Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Peng","family":"Feng","sequence":"additional","affiliation":[{"name":"Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Bo","family":"Niu","sequence":"additional","affiliation":[{"name":"The Third Affiliated Hospital of Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Song","sequence":"additional","affiliation":[{"name":"Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Bo","family":"Cui","sequence":"additional","affiliation":[{"name":"Zhengzhou Central Hospital Affiliated to Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai-Yang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Zhengzhou University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,20]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(92)90385-p"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23041998"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2010.11.001"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2024.2368742"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2018.1414183"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2024.2348068"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12033-024-01061-5"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116678"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/biom10020179"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c01248"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2026.117716"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40487-025-00410-x"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2996"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2007.11.031"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26144250"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/biom15091233"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23126381"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-015-0117-5"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M509188200"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1265-1"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v28.i1.123"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1039\/d5ra01880c"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201108078"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmr.2023.01.013"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11111683"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/cbdd.13808"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.05.041"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.scib.2026.02.048"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm800483v"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.2174\/0929867328666210331143827"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156135"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm500784e"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.117328"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.172643"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0969-2126(02)00717-7"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.2014.948845"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-026-04325-z"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-025-10296-7"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/17568919.2026.2648996"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.106895"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116913"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.2174\/187152010794728648"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c00459"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-025-02215-8"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2026.2704735"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09799-4"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-018-0032-z"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.Mct-16-0282"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-015-0282-y"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.e16337"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.4161\/15384101.2014.949550"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b00487"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.11729"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/mc.20380"},{"key":"e_1_3_4_57_1","unstructured":"Kim SE Lee YH Lee SH et al. inventors; Oncobix Co. Ltd. assignee. Preparation of pyrimidine derivative as FAK inhibitor and anticancer patent KR2023072550. 2023."},{"key":"e_1_3_4_58_1","unstructured":"Xie Y Liu W Qian L inventors; Wigen biomedicine technology (Shanghai) Co. Ltd. assignee. Compound As FAK Inhibitor Use Thereof Patent WO2023160614. 2023."},{"key":"e_1_3_4_59_1","unstructured":"Zhang H Li Y inventors; Beijing Normal University assignee. Preparation of diaminopyrimidine compound targeting focal adhesion kinase and its application in preparation of tumor therapeutic drug or tumor diagnostic imaging agent patent WO2023193795. 2023."},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.117593"},{"key":"e_1_3_4_61_1","unstructured":"Yan L Long Z Zuo Y et al. inventors; Pyrimidine compound containing thiophene its preparation method and application in preparation of antitumor drug patent CN114213400. Guizhou University assignee. 2022."},{"key":"e_1_3_4_62_1","unstructured":"Zhang H Zhuo S Hu Y et al. inventors; Signet Therapeutics Inc. assignee. Process fro preparation of pyrimidine or pyridine derivative and medicinal use thereof patent WO2023109751. 2023."},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115192"},{"key":"e_1_3_4_64_1","unstructured":"Kang F Liu J Zhang J et al. inventors; Central South University assignee. Preparation of 2 4-dianiline pyrimidine derivatives as FAK kinase inhibitors for prevention and\/or treatment of tumors patent CN116425735. 2023."},{"key":"e_1_3_4_65_1","unstructured":"Mo M Huang Y Zhu Y inventors; Plastech Pharmaceutical Technology Co. Ltd. assignee. Fused tricyclic derivatives as FAK inhibitors and their preparation pharmaceutical compositions and use in the treatment of diseases patent WO2024140671. 2024."},{"key":"e_1_3_4_66_1","unstructured":"Yin Y Li R Lin Z et al. inventors; Peking University assignee. Preparation of sulfonamide compounds as FAK kinase inhibitor for treatment and\/or prevention of cancer patent CN116969897. 2023."},{"key":"e_1_3_4_67_1","unstructured":"Chen L Chu P Zheng X et al. inventors; Preparation of 2-arylaminopyrimidine compounds as focal adhesion kinase inhibitors for treating breast cancer patent CN121378269. Dalian Medical University assignee. 2026."},{"key":"e_1_3_4_68_1","unstructured":"Xu X Chi X Chen R et al. inventors; The first People\u2019s Hospital of Yongkang Hangzhou Medical college assignee. In-depth learning-based fak inhibitor hybrid virtual screening method patent CN120279997. 2025."},{"key":"e_1_3_4_69_1","unstructured":"Yin Y Li R Lin Z inventors; Preparation of 3-sulfamoylbenzamide derivatives and their applications patent WO2026158305. Peking University assignee. 2026."},{"key":"e_1_3_4_70_1","unstructured":"Chen A. inventorPreparation of quinazoline derivatives as FAK inhibitor for treatment of cancer patent CN111848585. 2020."},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.0c00338"},{"key":"e_1_3_4_72_1","unstructured":"Gray N Scott D Groendyke B et al. inventors; Dana-Farber cancer Institute Inc. assignee. Preparation of substituted 4 9-dihydro-10H-pyrimido[5 4-b]thiazolo[5 4-e][1 4]diazepin-10-ones as small-molecule focal adhesion kinase (FAK) inhibitors patent WO2020231726. 2020."},{"key":"e_1_3_4_73_1","unstructured":"Zhang H Zhuo S Dai C et al. inventors; Signet Therapeutics Inc. assignee. Pyrrolopyrimidine or pyrrolopyridine derivative and medical use thereof patent WO2023036252. 2023."},{"key":"e_1_3_4_74_1","unstructured":"Zeng S Huang W Wang Z et al. inventors; Hangzhou Medical College assignee. Preparation of azaheterocyclic compounds as FAK inhibitors for treatment or prevention of cancer patent CN116478168. 2023."},{"key":"e_1_3_4_75_1","unstructured":"Chen L Yu J Zheng X et al. inventors; Dalian Medical University assignee. Preparation of 2-arylamino pyrimidine compounds and their application as anti-tumor drugs patent CN120698987. 2025."},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.S257494"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116246"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113569"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2014.04.041"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113116"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.12659\/msm.913479"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.200717"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.117646"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02203-1"},{"key":"e_1_3_4_85_1","unstructured":"Ki MH Kwon HS Lee YH et al. inventors; Samjin Pharmaceutical Co. Ltd. Incheon National University Research Business Foundation Bamichem Co. Ltd. assignee. Preparation of adamantane derivatives as inhibitors of focal adhesion kinase patent WO2021111311. 2021."},{"key":"e_1_3_4_86_1","unstructured":"Sun J Fang Z Zhang Y et al. inventors; Zhejiang University of Science & technology assignee. Preparation method of FAK\/PLK1 dual-target quinazoline derivatives and application thereof in preparation of drugs for treating cancer patent CN114105892. 2022."},{"key":"e_1_3_4_87_1","unstructured":"Wang H Gao J Liu X et al. inventors; InxMed (Nanjing) Co. Ltd. assignee. Preparation of heterocyclic compounds useful as focal adhesion kinase (FAK) inhibitors patent WO2026086879. 2026."},{"key":"e_1_3_4_88_1","unstructured":"Chinnaiyan AM Chugh S inventors; The Regents of the University of Michigan assignee. Methods for treating neuroblastoma with a dual anaplastic lymphoma kinase and focal adhesion kinase inhibitor patent WO2024178339. 2024."},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116166"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114373"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2026.118703"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.accounts.5c00003"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108846"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2026.109944"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.109380"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cclet.2025.112263"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cclet.2024.110456"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.141230798"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107984"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1080\/17460441.2019.1659242"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202109237"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.202300141"},{"key":"e_1_3_4_103_1","unstructured":"Gray NS Jiang B Nabet B et al. inventors; Dana-Farber Cancer Institute Inc. assignee. Degradation of FAK or fac and alk by conjugation of fac and alk inhibitors with E3 ligase ligands and methods of use patent WO2020069117. 2020."},{"key":"e_1_3_4_104_1","unstructured":"Zhao D Wang R Cheng M et al. inventors; Shenyang Pharmaceutical University assignee. Preparation of pyrazine derivatives and used as degradation of focal adhesion kinase and antitumor agents patent WO2022028372. 2022."},{"key":"e_1_3_4_105_1","unstructured":"Zhao D Wang R Cheng M et al. inventors; Shenyang Pharmaceutical University assignee. Compound for targeted degradation of focal adhesion kinase (FAK) and its application in preparation of FAK inhibitor and drug for treating or preventing tumor-related disease patent WO2021190413. 2021."},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5c00921"},{"key":"e_1_3_4_107_1","unstructured":"Yu L Wei W inventors; Sichuan University assignee. Preparation of 7-[[2-(2-methoxyanilino)-7H-pyrrolo[2 3-d]pyrimidin-4-yl]oxy]indan-1-one derivatives as FAK degradation agent for prevention and\/or treatment of FAK protein-associated tumors patent CN115403583. 2022."},{"key":"e_1_3_4_108_1","unstructured":"Yu L inventor; Chengdu Degeng Biotechnology Co. Ltd. assignee. FAK protein degradation targeting chimeric degraders and methods for their preparation patent CN120865212. 2025."},{"key":"e_1_3_4_109_1","unstructured":"Ding X Liu J Qin L et al. inventors; Berrybio (Shanghai) limited assignee. Preparation of pyridinamine and pyrimidinamine derivatives as FAK degraders pharmaceutical compositions and therapeutic applications patent WO2023185920. 2023."},{"key":"e_1_3_4_110_1","unstructured":"Chen J Zhang X Xu M et al. inventors; Nanjing Bestfluorodrug Pharmaceutical Technology Co. Ltd. assignee. Preparation of oxoisoindolinyl pyrimidine based FAK protein targeted chimera compounds as antitumor agents patent CN120289430. 2025."},{"key":"e_1_3_4_111_1","unstructured":"Cashion DK Moreno J Peters DS et al. inventors; Bristol-myers Squibb company assignee. Preparation of 3-[5-[(1H-pyrazolo[3 4-b]pyridin-1-yl)methyl]-1-oxo-2 3-dihydro-1H-isoindol-2-yl]piperidine-2 6-dione derivatives and analogs as FAK degraders for treating cancers patent WO2025199379. 2025."},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.1080\/17568919.2026.2679002"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.Am2026-5987"},{"key":"e_1_3_4_114_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adt8706"},{"key":"e_1_3_4_115_1","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.70192"},{"key":"e_1_3_4_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.109097"},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2026.115837"},{"key":"e_1_3_4_118_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00340-6"},{"key":"e_1_3_4_119_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2024.2417762"},{"key":"e_1_3_4_120_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-02974-4"},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.33696\/cancerimmunol.7.109"},{"key":"e_1_3_4_122_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ado2402"},{"key":"e_1_3_4_123_1","unstructured":"Banerji U inventor; The Institute of cancer research Royal cancer Hospital assignee. vs-6063 in combination with CH5126766 for the treatment of cancer patent WO2021047798. 2021."},{"key":"e_1_3_4_124_1","unstructured":"Zhou F Dou H Yang G et al. inventors; Shandong Simcere Zaiming Biopharmaceutical Co. Ltd. assignee. Combination of pan-RAS inhibitor and FAK inhibitor patent WO2026057037. 2026."},{"key":"e_1_3_4_125_1","doi-asserted-by":"publisher","DOI":"10.1515\/jtim-2025-0051"},{"key":"e_1_3_4_126_1","doi-asserted-by":"publisher","DOI":"10.1007\/s42114-025-01242-z"},{"key":"e_1_3_4_127_1","unstructured":"Zhong Y Ding A Xu B et al. inventors; Meizhou People\u2019s Hospital (meizhou Academy of Medical Sciences) assignee. Use of defactinib in preparation of drugs for treatment of keloid scar through inhibition of FAK-YAP signaling pathway patent CN121731310. 2026."},{"key":"e_1_3_4_128_1","unstructured":"Zhang B Pang R Liu X et al. inventors; InxMed (Nanjing) Co. Ltd. assignee. FAK inhibitors and uses for treating or preventing interstitial pneumonia patent WO2026026944. 2026."},{"key":"e_1_3_4_129_1","unstructured":"Gao M Qin J Ma S et al. inventors; Application of FAK inhibitor in preparing medicament for treating acute pancreatitis patent CN121570468. Harbin Institute of Technology assignee. 2026."}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2026.2735861","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/13543776.2026.2735861","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2026.2735861","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:25:14Z","timestamp":1793618714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2026.2735861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,20]]},"references-count":127,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11,2]]}},"alternative-id":["10.1080\/13543776.2026.2735861"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2026.2735861","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-06-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}